{"id":48527,"date":"2022-09-19T13:02:00","date_gmt":"2022-09-19T11:02:00","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/"},"modified":"2022-09-19T13:02:00","modified_gmt":"2022-09-19T11:02:00","slug":"akili-to-participate-in-lifesci-partners-healthtech-symposium","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/","title":{"rendered":"Akili to Participate in LifeSci Partners HealthTech Symposium"},"content":{"rendered":"<div>\n<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that management will present at a fireside chat and participate in a panel discussion on prescription digital therapeutics at the virtual LifeSci Partners HealthTech Symposium on Tuesday, September 20, 2022.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220919005164\/en\/689868\/5\/Akili_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220919005164\/en\/689868\/21\/Akili_Logo.jpg\"><\/a><\/p>\n<p>\nDetails are as follows:\n<\/p>\n<p>\n<b>Format:<\/b> Presentation and Fireside Chat<br \/>\n<br \/><b>Time:<\/b> 9:30 a.m. ET\n<\/p>\n<p>\n<b>Format:<\/b> Panel Discussion<br \/>\n<br \/><b>Topic:<\/b> Prescription Digital Therapeutics<br \/>\n<br \/><b>Time:<\/b> 11:30 a.m. ET\n<\/p>\n<p>\nLive and archived webcasts of the fireside chat and panel discussion will be available on the Investors section of Akili\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.akiliinteractive.com&amp;esheet=52913048&amp;newsitemid=20220919005164&amp;lan=en-US&amp;anchor=www.akiliinteractive.com&amp;index=1&amp;md5=d832fb6dce28ed2154bc38a65498dbaa\" rel=\"nofollow noopener\" shape=\"rect\">www.akiliinteractive.com<\/a>.\n<\/p>\n<p>\n<b>About Akili<\/b>\n<\/p>\n<p>\nAkili is pioneering the development of cognitive treatments through game-changing technologies. Our approach of leveraging technologies designed to directly target the brain establishes a new category of medicine \u2013 medicine that is validated through clinical trials like a drug or medical device but experienced like entertainment. Akili\u2019s platform is powered by proprietary therapeutic engines designed to target cognitive impairment at its source in the brain, informed by decades of research and validated through rigorous clinical programs. Driven by Akili\u2019s belief that effective medicine can also be fun and engaging, Akili\u2019s products are delivered through captivating action video game experiences. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.akiliinteractive.com&amp;esheet=52913048&amp;newsitemid=20220919005164&amp;lan=en-US&amp;anchor=www.akiliinteractive.com&amp;index=2&amp;md5=af16390274bcba5fa7356f1bb361e1c2\" rel=\"nofollow noopener\" shape=\"rect\">www.akiliinteractive.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contact:<\/b><br \/>Joshua Young<br \/>\n<br \/>VP of Investor Relations<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;l&#116;&#x6f;&#x3a;j&#121;&#x6f;&#x75;n&#103;&#x40;a&#107;&#x69;&#x6c;i&#105;&#x6e;&#x74;e&#114;&#x61;c&#116;&#x69;&#x76;e&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#106;&#121;&#x6f;&#x75;&#110;&#103;&#x40;&#x61;&#107;&#105;&#x6c;&#x69;&#105;&#110;&#x74;&#x65;&#114;&#97;&#x63;&#x74;&#105;&#118;&#x65;&#x2e;&#99;&#111;&#x6d;<\/a>\n<\/p>\n<p>\n<b>Media Contact:<\/b><br \/>Julie DiCarlo<br \/>\n<br \/>SVP, Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;&#x3a;&#x6a;u&#x6c;&#105;&#x65;&#64;&#x61;&#107;i&#x6c;&#105;&#x69;&#110;&#x74;&#101;r&#x61;&#99;&#x74;&#105;&#x76;&#101;&#46;&#x63;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6a;&#x75;&#108;ie&#x40;&#x61;&#107;&#105;l&#x69;&#x69;&#110;&#116;e&#x72;&#x61;&#x63;&#116;iv&#x65;&#x2e;&#99;&#111;m<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON&#8211;(BUSINESS WIRE)&#8211;Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that management will present at a fireside chat and participate in a panel discussion on prescription digital therapeutics at the virtual LifeSci Partners HealthTech Symposium on Tuesday, September 20, 2022. Details are as follows: Format: Presentation and Fireside Chat Time: 9:30 a.m. ET &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48527","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Akili to Participate in LifeSci Partners HealthTech Symposium - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Akili to Participate in LifeSci Partners HealthTech Symposium - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BOSTON&#8211;(BUSINESS WIRE)&#8211;Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that management will present at a fireside chat and participate in a panel discussion on prescription digital therapeutics at the virtual LifeSci Partners HealthTech Symposium on Tuesday, September 20, 2022. Details are as follows: Format: Presentation and Fireside Chat Time: 9:30 a.m. ET ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-19T11:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220919005164\/en\/689868\/21\/Akili_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Akili to Participate in LifeSci Partners HealthTech Symposium\",\"datePublished\":\"2022-09-19T11:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/\"},\"wordCount\":232,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005164\\\/en\\\/689868\\\/21\\\/Akili_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/\",\"name\":\"Akili to Participate in LifeSci Partners HealthTech Symposium - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005164\\\/en\\\/689868\\\/21\\\/Akili_Logo.jpg\",\"datePublished\":\"2022-09-19T11:02:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005164\\\/en\\\/689868\\\/21\\\/Akili_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005164\\\/en\\\/689868\\\/21\\\/Akili_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/akili-to-participate-in-lifesci-partners-healthtech-symposium\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Akili to Participate in LifeSci Partners HealthTech Symposium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Akili to Participate in LifeSci Partners HealthTech Symposium - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/","og_locale":"en_US","og_type":"article","og_title":"Akili to Participate in LifeSci Partners HealthTech Symposium - Pharma Trend","og_description":"BOSTON&#8211;(BUSINESS WIRE)&#8211;Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that management will present at a fireside chat and participate in a panel discussion on prescription digital therapeutics at the virtual LifeSci Partners HealthTech Symposium on Tuesday, September 20, 2022. Details are as follows: Format: Presentation and Fireside Chat Time: 9:30 a.m. ET ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-19T11:02:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220919005164\/en\/689868\/21\/Akili_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Akili to Participate in LifeSci Partners HealthTech Symposium","datePublished":"2022-09-19T11:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/"},"wordCount":232,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220919005164\/en\/689868\/21\/Akili_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/","url":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/","name":"Akili to Participate in LifeSci Partners HealthTech Symposium - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220919005164\/en\/689868\/21\/Akili_Logo.jpg","datePublished":"2022-09-19T11:02:00+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220919005164\/en\/689868\/21\/Akili_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220919005164\/en\/689868\/21\/Akili_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/akili-to-participate-in-lifesci-partners-healthtech-symposium\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Akili to Participate in LifeSci Partners HealthTech Symposium"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48527"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48527\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}